Full text loading...
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Reporting and analyzing dose distributions: A concept of equivalent uniform dose
1.J. A. Purdy, “Volume and dose specification for 3D conformal radiation therapy,” in Proceedings of “3D Radiation Treatment Planning and Conformal Therapy” an International Symposium, St. Louis, MO, 1993.
2.IAEA, “Radiation dose in radiotherapy from prescription to delivery,” Proceedings of the Interregional Seminar for Europe, the Middle East and Africa Organized by the IAEA, Leuven, 1994.
3.ICRU Report 50. Prescribing, recording, and reporting photon beam therapy (International Commission on Radiation Units and Measurements, Washington, DC, 1993).
4.R. E. Drzymala, R. Mohan, L. Brewster, J. Chu, M. Goitein, W. Harms, and M. Urie, “Dose-volume histograms,” Int. J. Radiat. Oncol., Biol., Phys. 21, 71–78 (1991).
5.A. Niemierko and M. Goitein. “Dose-volume distributions (DVD’s): A new approach to dose-volume histograms in three-dimensional treatment planning,” Med. Phys. 21, 3–11 (1994).
6.A. Brahme, “Dosimetric precision requirements in radiation therapy,” Acta Radiol.: Oncol. 23, 379–391 (1984).
7.P. Aaltonen, “An inventory of dose specification in the Nordic centres and a suggestion for a standardized procedure,” in Ref. 2.
8.A. Brahme, “Which parameters of the dose distribution are best related to the radiation response of tumours and normal tissues?,” in Ref. 2.
9.A. Soderstromand A. Brahme, “Optimization of the dose delivery in a few field techniques using radiobiological objective functions,” Med. Phys. 20, 1201–1210 (1993).
10.M. Goitein, A. Niemierko, and P. Okunieff, “The probability of controlling an inhomogeneously irradiated tumor: A stratagem for improving tumor control through partial tumor boosting,” Br. J. Radiol. (in press).
11.M. Goitein, “The probability of controlling an inhomogeneously irradiated tumor,” in Report of the Working Groups on the Evaluation of Treatment Planning for Particle Beam Radiotherapy, published by the Radiotherapy Development Branch, Radiation Research Program, Division of Cancer Treatment (National Cancer Institute, Bethesda, 1987).
12.A. Jackson, G. J. Kutcher, and E. D. Yorke, “Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation,” Med. Phys. 20, 613–625 (1993).
13.A. Jackson, R. K. Ten Haken, J. M. Robertson, M. L. Kessler, G. J. Kutcher, and T. S. Lawrence, “Analysis of clinical complication data for radiation hepatitis using a parallel architecture model,” Int. J. Radiat. Oncol., Biol., Phys. 31, 883–891 (1995).
14.G. J. Kutcher and C. Burman, “Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method,” Int. J. Radiat. Oncol., Biol., Phys. 16, 1623–1630 (1989).
15.T. S. Lawrence, R. K. Ten Haken, M. L. Kessler, J. M. Robertson, J. T. Lyman, M. L. Lavigne, M. B. Brown, D. J. DuRoss, J. C. Andrews, W. D. Ensminger, and A. S. Lichter, “The use of 3-D dose volume analysis to predict radiation hepatitis,” Int. J. Radiat. Oncol., Biol., Phys. 23, 781–788 (1992).
16.J. T. Lyman, “Complication probability as assessed from dose-volume histograms,” Radiat. Res. 104, 13–19 (1985).
17.A. Niemierko, M. Urie, and M. Goitein, “Optimization of 3D radiation therapy with both physical and biological end points and constraints,” Int. J. Radiat. Oncol., Biol., Phys. 23, 99–108 (1992).
18.A. Niemierko and M. Goitein, “Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor,” Radiother. Oncol. 29, 140–147 (1993).
19.M. Langer, P. Kijewski, R. Brown, and C. Ha, “The effect of minimum tumor dose of restricting target-dose inhomogeneity in optimized three-dimensional treatment of lung cancer,” Radiother. Oncol. 21, 245–256 (1991).
20.R. Mohan, X. Wang,A. Jackson, T. Bortfeld, A. L. Boyer, G. J. Kutcher, S. A. Leibel, Z. Fuks, and C. C. Ling, “The potential and limitations of the inverse radiotherapy technique,” Radiother. Oncol. 32, 232–248 (1994).
21.D. J. Brenner, “Dose, volume, and tumor-control predictions in radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 26, 171–179 (1993).
22.T. E. Schultheiss, “Radiation dose-response models,” in Radiation Therapy Physics, edited by A. Smith (Spring-Verlag, New York, 1995).
23.H. D. Thames and J. H. Hendry, Fractionation in Radiotherapy (Taylor & Francis Ltd., London, 1987).
24.J. F. Fowler, “The linear-quadratic formula and progress in fractionated radiotherapy,” Br. J. Radiol. 62, 679–694 (1989).
25.S. M. Bentzen, “Radiobiological considerations in the design of clinical trials,” Radiother. Oncol. 32, 1–11 (1994).
26.S. M. Bentzen, “Quantitative clinical radiobiology,” Acta Oncol. 32, 259–275 (1993).
27.P. Okunieff, D. Morgan, A. Niemierko, and H. Suit, “Radiation dose response of human tumors,” Int. J. Radiat. Oncol., Biol., Phys. 32, 1227–1237 (1995).
28.J. J. Fisher, “Theoretical considerations in optimization of dose distribution in radiation therapy,” Br. J. Radiol. 42,925–930 (1969).
Article metrics loading...